脑出血后抑郁发病与治疗与血压控制的关联
研究基于2006至2018年麻省总医院单中心纵向脑出血队列,纳入1243例无卒中前抑郁史的患者。中位随访52.8个月期间721例(58%)新发抑郁,抑郁发病与收缩压和舒张压后续升高相关,抑郁症状缓解与血压后续下降相关。使用选择性5-羟色胺再摄取抑制剂或去甲肾上腺素-5-羟色胺再摄取抑制剂类抗抑郁药与收缩压升高独立相关。
要点
- 脑出血后新发抑郁与收缩压和舒张压后续升高相关。
- 抑郁症状缓解与收缩压和舒张压后续下降相关。
- 使用选择性5-羟色胺再摄取抑制剂或去甲肾上腺素-5-羟色胺再摄取抑制剂类抗抑郁药与收缩压升高独立相关。
核心结论
- 脑出血存活者被诊断为抑郁后血压值升高,而抑郁症状缓解者血压值随后下降。
- 使用选择性5-羟色胺再摄取抑制剂和去甲肾上腺素-5-羟色胺再摄取抑制剂类抗抑郁药与收缩压测量值升高独立相关。
- 作者建议临床医生应密切监测因抑郁接受治疗的脑出血存活者的血压,尤其是使用选择性5-羟色胺再摄取抑制剂和去甲肾上腺素-5-羟色胺再摄取抑制剂者。
- 作者指出未来仍需研究来探究这些关联的机制。
研究设计与样本
- 研究为麻省总医院(波士顿,马萨诸塞州)2006年至2018年间开展的单中心纵向脑出血研究。
- 数据来自电子健康记录的半自动审查、基线和随访访谈以及计算机断层扫描成像。
- 共纳入1243例无卒中前抑郁史的连续脑出血患者。
- 血压测量、抑郁诊断、抗抑郁药使用和就医信息纵向收集,并使用混合效应模型分析。
- 主要结局为脑出血后长期随访期间的收缩压和舒张压测量值。
主要发现
- 1243例患者中721例(58%)在中位随访52.8个月(四分位距42.1-60.5)内被诊断为新发抑郁。
- 抑郁发病与随后收缩压升高8.3 mm Hg(标准误2.4 mm Hg,P=0.012)和舒张压升高4.4 mm Hg(标准误1.2 mm Hg)相关。
- 抑郁症状缓解与随后收缩压降低5.9 mm Hg(标准误1.4 mm Hg,P=0.031)和舒张压降低3.4 mm Hg(标准误1.1 mm Hg,P=0.041)相关。
- 较高的收缩压测量值与使用选择性5-羟色胺再摄取抑制剂和去甲肾上腺素-5-羟色胺再摄取抑制剂类抗抑郁药相关,与抑郁症状是否活跃无关(所有P<0.05)。
临床怎么用
- 作者建议临床医生应密切监测因抑郁接受治疗的脑出血存活者的血压,尤其是使用选择性5-羟色胺再摄取抑制剂和去甲肾上腺素-5-羟色胺再摄取抑制剂者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Blood pressure (BP) control represents a crucial intervention to improve long-term outcomes following spontaneous intracerebral hemorrhage (ICH). However, fewer than half of ICH survivors achieve target treatment goals. ICH survivors are also at very high risk for poststroke depression, which may contribute to inadequate BP control. We, therefore, sought to determine whether depressive symptoms after ICH are associated with inadequate BP control. We also investigated whether associations between depression after ICH and BP measurements were mediated by treatment with selective serotonin reuptake inhibitors or norepinephrine-serotonin reuptake inhibitors antidepressants. METHODS: We leveraged data from a single-center longitudinal study of ICH conducted at Massachusetts General Hospital (Boston, MA) between 2006 and 2018. We collected data from semiautomated review of electronic health records, baseline and follow-up interviews, and computed tomography imaging. Information on BP measurements, depression diagnoses, antidepressants medication use, and medical visits were collected longitudinally and analyzed using mixed effects models. Primary outcomes included systolic and diastolic BP measurements during long-term follow-up after ICH. RESULTS: We included 1243 consecutive ICH patients without pre-stroke depression history. Of these, 721 (58%) were diagnosed with incident depression over a median follow-up time of 52.8 months (interquartile range, 42.1-60.5). Depression onset was associated with subsequent increase in systolic (+8.3 mm Hg, SE, 2.4 mm Hg, P=0.012) and diastolic (+4.4 mm Hg, SE, 1.2 mm Hg) BP measurements. Resolution of depressive symptoms was associated with subsequent decrease in systolic (-5.9 mm Hg, SE, 1.4 mm Hg, P=0.031) and diastolic (-3.4 mm Hg, SE, 1.1 mm Hg, P=0.041) BP measurements. We also found associations between higher systolic BP measurements and use of selective serotonin reuptake inhibitor and noradrenaline-serotonin reuptake inhibitor antidepressants, independent of whether depression symptoms were active or not (all P<0.05). CONCLUSIONS: ICH survivors displayed increasing BP values after receiving a diagnosis of depression, followed by decreasing values among those experiencing resolution of depressive symptoms. Use of selective serotonin reuptake inhibitor and noradrenaline-serotonin reuptake inhibitor antidepressants was independently associated with higher systolic BP measurements. Clinicians ought to closely monitor BP for ICH survivors being treated for depression, especially using selective serotonin reuptake inhibitor and noradrenaline-serotonin reuptake inhibitor. Future studies will also be required to investigate the mechanisms underlying these associations.
引用
- Keins S, Abramson JR, Mallick A, et al. Association of Depression Onset and Treatment With Blood Pressure Control After Intracerebral Hemorrhage. Stroke. 2022. PMID: 36444719. doi:10.1161/STROKEAHA.122.040331
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。